A randomised, non-blinded, three fold crossover study investigating the effect of finerenone on the pharmacokinetics of the repaglinide in healthy male volunteers
Latest Information Update: 06 Mar 2020
At a glance
- Drugs Finerenone (Primary) ; Repaglinide
- Indications Chronic heart failure; Diabetic nephropathies
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 06 Mar 2020 New trial record
- 03 Mar 2020 Results from drug drug interaction studies investigation the effect of Finerenone on PK of comedications published in the European Journal of Drug Metabolism and Pharmacokinetics